Perkins Capital Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.59M Sell
168,842
-59,492
-26% -$1.93M 5.24% 3
2025
Q4
$7.47M Sell
228,334
-7,717
-3% -$190K 5.93% 3
2025
Q3
$4.21M Sell
236,051
-2,683
-1% -$38.9K 3.71% 6
2025
Q2
$2.59M Sell
238,734
-14,800
-6% -$194K 2.6% 10
2025
Q1
$4.69M Sell
253,534
-7,690
-3% -$139K 4.95% 3
2024
Q4
$4.3M Sell
261,224
-22,175
-8% -$314K 3.82% 5
2024
Q3
$3.97M Sell
283,399
-5,950
-2% -$65.8K 3.73% 5
2024
Q2
$2.1M Sell
289,349
-8,600
-3% -$58.8K 1.97% 12
2024
Q1
$2.4M Sell
297,949
-1,666
-0.6% -$14.9K 2% 13
2023
Q4
$2.05M Sell
299,615
-1,725
-0.6% -$9.59K 1.75% 13
2023
Q3
$1.51M Buy
301,340
+2,450
+0.8% +$17K 1.49% 22
2023
Q2
$2.73M Sell
298,890
-10,600
-3% -$98.8K 2.38% 11
2023
Q1
$2.92M Buy
309,490
+2,450
+0.8% +$22.4K 2.76% 7
2022
Q4
$3.06M Buy
307,040
+400
+0.1% +$4.44K 3.23% 5
2022
Q3
$3.65M Buy
306,640
+700
+0.2% +$7K 4.09% 3
2022
Q2
$2.51M Buy
305,940
+17,750
+6% +$152K 2.59% 10
2022
Q1
$2.29M Buy
288,190
+11,000
+4% +$95K 1.88% 16
2021
Q4
$2.6M Buy
277,190
+3,950
+1% +$47.4K 1.75% 18
2021
Q3
$4.32M Buy
273,240
+400
+0.1% +$7.18K 2.67% 8
2021
Q2
$5.9M Sell
272,840
-4,650
-2% -$94K 3.35% 6
2021
Q1
$5.62M Hold
277,490
3.25% 7
2020
Q4
$4.97M Sell
277,490
-8,700
-3% -$128K 3.25% 8
2020
Q3
$3.33M Buy
+286,190
New +$3.32M 3.06% 9
2020
Q1
$3.1M Buy
298,240
+1,450
+0.5% +$18.5K 3.75% 3
2019
Q4
$5.31M Sell
296,790
-22,985
-7% -$340K 4.76% 3
2019
Q3
$3.99M Sell
319,775
-20,000
-6% -$329K 3.44% 3
2019
Q2
$6.73M Sell
339,775
-9,350
-3% -$200K 4.71% 2
2019
Q1
$7.35M Sell
349,125
-7,050
-2% -$129K 4.84% 2
2018
Q4
$7.28M Sell
356,175
-2,825
-0.8% -$88.4K 5.64% 2
2018
Q3
$13.2M Sell
359,000
-6,675
-2% -$291K 7.94% 1
2018
Q2
$18.4M Sell
365,675
-62,575
-15% -$2.76M 13.16% 1
2018
Q1
$15.6M Sell
428,250
-65,900
-13% -$2.02M 14.07% 1
2017
Q4
$14M Sell
494,150
-45,448
-8% -$1.07M 13.45% 1
2017
Q3
$10.4M Sell
539,598
-15,194
-3% -$255K 10.94% 1
2017
Q2
$9.29M Sell
554,792
-37,375
-6% -$504K 10.31% 1
2017
Q1
$6.19M Sell
592,167
-3,741
-0.6% -$38.2K 6.38% 1
2016
Q4
$5.36M Sell
595,908
-25,000
-4% -$215K 5.88% 1
2016
Q3
$5.61M Sell
620,908
-11,000
-2% -$89.4K 5.61% 1
2016
Q2
$4.35M Sell
631,908
-1,225
-0.2% -$6.93K 4.98% 3
2016
Q1
$3.39M Sell
633,133
-10,625
-2% -$53.9K 4.25% 4
2015
Q4
$3.22M Sell
643,758
-18,942
-3% -$93.6K 3.45% 4
2015
Q3
$2.73M Buy
662,700
+29,450
+5% +$118K 3.04% 4
2015
Q2
$1.99M Sell
633,250
-17,800
-3% -$57.5K 1.75% 13
2015
Q1
$2.28M Buy
651,050
+255,000
+64% +$876K 1.91% 7
2014
Q4
$1.42M Buy
396,050
+27,300
+7% +$79.9K 1.22% 22
2014
Q3
$900K Sell
368,750
-6,000
-2% -$14.7K 0.76% 48
2014
Q2
$1.04M Hold
374,750
0.73% 50
2014
Q1
$1.14M Sell
374,750
-19,450
-5% -$77.5K 0.8% 47
2013
Q4
$1.77M Sell
394,200
-8,800
-2% -$35.8K 1.19% 29
2013
Q3
$1.79M Buy
+403,000
New +$1.48M 1.29% 24

Other funds holding AXGN

Perkins Capital Management's AXGN Position: Q1 2026 in Review

Perkins Capital Management reduced its Axogen (AXGN) stake by 26% in Q1 2026, selling an estimated $1.93M and leaving 168,842 shares worth $5.59M. The position accounts for 5.24% of the portfolio, ranked #3.

Perkins Capital Management first reported a position in AXGN in Q3 2013 and has held it in 50 quarters since. The position peaked at $18.4M in Q2 2018. 220 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • Perkins Capital Management held 168,842 shares of Axogen worth $5.59M as of Q1 2026.
  • Perkins Capital Management sold 59,492 Axogen shares in Q1 2026, an estimated $1.93M.
  • Axogen made up 5.24% of Perkins Capital Management's portfolio in Q1 2026, its #3 holding.
  • Perkins Capital Management first reported a position in Axogen in Q3 2013 and has held it in 50 quarters since.
  • Perkins Capital Management's Axogen position peaked at $18.4M in Q2 2018.
  • 220 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on Perkins Capital Management's 13F filing for Q1 2026, filed 23 Apr 2026.